MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Ceftriaxone improves motor function in a rat hemi-parkinsonian model: Potential to delay bilateral progression of motor deficits in Parkinson’s disease

    E. Kasanga, C. McElroy, M. Salvatore (Fort Worth, TX, USA)

    Objective: This study sought to evaluate the impact of ceftriaxone, as a potential repurposed drug, in ameliorating motor decline in a unilateral rat 6-hydroxydopamine (6-OHDA)…
  • MDS Virtual Congress 2020

    Comparison of the effect of hydroalcoholic extract of olive leaf and levodopa on reducing parkinson’s symptoms in animal model

    M. Modaresi (Isfahan, Islamic Republic of Iran)

    Objective: Today, the use of medicinal herbs to prevent and slow down the progression of Parkinson's disease has attracted the attention of researchers. The phenolic…
  • MDS Virtual Congress 2020

    Anticholinergic Burden in Parkinson’s Disease Patients in India – A Hospital Based Study

    A. Saini, R. Rajan, R. Anandapadmanabhan, V. Venogopalan, A. Gupta, B. Verma, N. Choudhary, R. Bhatia, M. Singh, A. Srivastava, P. Srivastava (New Delhi, India)

    Objective: To determine the cumulative anticholinergic burden in Indian Parkinson’s disease (PD) patients and to correlate the same with cognitive impairment and gait disturbance. Background:…
  • MDS Virtual Congress 2020

    Effects of a next-generation neurotrophic compound in a toxin model of Parkinson’s disease

    T. Viljakainen, M. Saarma, M. Voutilainen (Helsinki, Finland)

    Objective: Investigate the effects of a peripherally administered novel neurotrophic compound, CMx01a, in 6-hydroxydopamine rat model of Parkinson’s disease. Background: Neurotrophic factors are promising drug…
  • MDS Virtual Congress 2020

    Brain 5-HT1 receptor binding in multiple system atrophy: A [18F]-MPPF PET study

    M. Meyer, I. Sibon, F. Lamarre, J. Asselineau, A. Foubert-Samier, J. Mazère, A. Delamarre, O. Rascol, A. Pavy-Le Traon, F. Tison, P. Fernandez, W. Meissner (Bordeaux, France)

    Objective: The primary objective was to compare brain 5-HT1a receptor binding between patients with multiple system atrophy (MSA) and healthy controls (HC). The secondary objectives…
  • MDS Virtual Congress 2020

    Glucocerebrosidase activity and atypical parkinsonism: a multi-centre exploratory study

    R. Alvarez Velasco, P. Giraldo, P. Irun, L. Vela Desojo, L. Lopez Manzanares, J.M Arbelo González, M. Eimil Ortiz, A. Rojo Sebastian, M. Mata Álvarez-Santullano, I. Martínez Torres, J. Garcia-Caldentey, M. Gómez Gutierrez, C. Estévez-Fraga, J.L López Sendón, G. García Ribas, J.C Martínez Castrillo, A. Alonso-Canovas (Madrid, Spain)

    Objective: We aimed to determine the frequency of Glucocerebrosidase (GBA) deficiency (subclinical Gaucher's Disease type 1, GD1) in patients with atypical parkinsonism (AP) with features…
  • MDS Virtual Congress 2020

    Key neuropathological features separating corticobasal degeneration from other related disorders

    S. Rezvanian, I. Litvan, D. Dickson (La Jolla, CA, USA)

    Objective: This study investigated the key neuropathological features that could separate corticobasal degeneration (CBD) from related parkinsonian disorders by using a decision tree algorithm. Background:…
  • MDS Virtual Congress 2020

    Staircase sign for Atypical and Secondary parkinsonism

    Y.S Oh, J.S Kim, D.Y Kwon, M.H Park, B.R Bloem (Seoul, Republic of Korea)

    Objective: The aim of this study was to investigate the difference in the preference of staircase climbing in PD and atypical/ secondary parkinsonism when they…
  • MDS Virtual Congress 2020

    Benign Infantile Tremor Syndrome (BITS): a new movement disorder

    M. Hull, M. Parnes (Houston, TX, USA)

    Objective: We present infants at our institution presented with action tremor with onset weeks to months later after birth and otherwise similar to neonatal jitteriness. Background: Several benign movement disorders in infancy have been described including…
  • MDS Virtual Congress 2020

    Simultaneous, levodopa-responsive Holmes’ tremor and hemiparkinsonism due to midbrain cavernous malformation

    A. Dessy, P. Drummond (New York, NY, USA)

    Objective: We report a case of concomitant Holmes’ tremor (HT) and hemiparkinsonism (HP) attributable to a single structural lesion with robust clinical response to levodopa.…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 149
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley